OLNEY, Md., July 07, 2022 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (Nasdaq: SASR) will announce its second quarter earnings on Thursday, July 21, 2022. The company will hold a conference call that day at 2:00 p.m. (ET) to discuss results and answer questions. The conference call will be webcast live through the Sandy Spring Bank website. Those who wish to participate in order to ask questions may do so by calling 1-844-200-6205; please use Access Code: 532489. Those who wish to listen to the call should go to the Investor Relations page of www.sandyspringbank.com and log on 10 minutes ahead of the scheduled start of the call. An internet-based replay will be available on the Investor Relations page of the website until August 4, 2022. A telephone voice replay will also be available during that same time period at 1-866-813-9403. Please use conference number 378796 to access.
About Sandy Spring Bancorp, Inc.
Sandy Spring Bancorp, Inc., headquartered in Olney, Maryland, is the holding company for Sandy Spring Bank, a premier community bank in the Greater Washington, D.C. region. With over 50 locations, the bank offers a broad range of commercial and retail banking, mortgage, private banking, and trust services throughout Maryland, Northern Virginia, and Washington, D.C. Through its subsidiaries, Rembert Pendleton Jackson and West Financial Services, Inc., Sandy Spring Bank also offers a comprehensive menu of wealth management services.
Source: Sandy Spring Bancorp, Inc.
For additional information or questions, please contact:
|Daniel J. Schrider, President & Chief Executive Officer, or
Philip J. Mantua, E.V.P. & Chief Financial Officer
Jen Schell, Vice President
- ROSEN, A TOP RANKED FIRM, Encourages Missfresh Limited Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm – MF - August 13, 2022
- ROSEN, A TOP RANKED FIRM, Encourages Wells Fargo & Company Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action – WFC - August 13, 2022
- Plus Therapeutics Presents Positive Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases - August 13, 2022